Alberto Fusi

Alberto Fusi

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.

Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.

Journal: Cancer discovery

Published: December 18, 2025

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 05, 2023

Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme.

Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: December 24, 2021

Life-threatening polymyositis with spontaneous hematoma induced by nivolumab in a patient with previously resected melanoma.

Life-threatening polymyositis with spontaneous hematoma induced by nivolumab in a patient with previously resected melanoma.

Journal: Melanoma research

Published: November 16, 2020

Effect of carboplatin when administered after dacarbazine failure: Clinical benefit of sequential therapy.

Effect of carboplatin when administered after dacarbazine failure: Clinical benefit of sequential therapy.

Journal: Molecular and clinical oncology

Published: February 11, 2020

The successful treatment of metastatic androgen receptor-positive tumours of parotid origin with androgen receptor blockade and immunotherapy.

The successful treatment of metastatic androgen receptor-positive tumours of parotid origin with androgen receptor blockade and immunotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 22, 2019

Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine.

Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine.

Journal: Translational oncology

Published: August 28, 2018

Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity.

Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity.

Journal: Journal of translational medicine

Published: May 17, 2018

The importance for immunoregulation for long-term cancer control.

The importance for immunoregulation for long-term cancer control.

Journal: Future oncology (London, England)

Published: August 05, 2017

Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma.

Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma.

Journal: Cancer cell

Published: March 16, 2017

Vasculogenic mimicry in small cell lung cancer.

Vasculogenic mimicry in small cell lung cancer.

Journal: Nature communications

Published: June 28, 2016

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.

Journal: Nature communications

Published: June 14, 2016

Showing 1-12 of 29

Last Updated: 09/26/2026